Back to results
US 2016/0243236 A1Published application
Hcd formulation for cancer treatment
AssigneeNational Dong Hwa University
InventorsChing-Feng Weng, Yi-Chen Chia, Chia-Hung Lee, T. Varadharajan
Life of this patent
Estimating the term…
Abstract
The present invention provides a novel formulation for cancer treatment and a method for enhancing the HCD's efficacy in cancer treatment. Specifically, the present invention provides copper-modified silica nanoparticles loaded with HCD, which exhibits better efficacy than some conventional anticancer drugs.
Claims20
A formulation for cancer treatment, comprising:
- a copper-modified silica nanoparticle;
- and
- a pharmaceutically acceptable carrier.
A method for enhancing the efficacy of 16-hydroxy-cleroda-3,13-dine-15,16-olide (HCD) for cancer treatment, comprising:
- loading said HCD to a copper-modified silica nanoparticle to obtain a copper-modified silica nanoparticle loaded with HCD.
Dependencies are inferred from the claim text.